Being the third most common cause of revision surgery following primary total hip arthroplasty (THA), peri-prosthetic joint infection (PJI) constitutes one of the most undesired complications, with a prevalence of 0.3% to 2
Treatment of bacterial septic arthritis in the native adult hip poses distinct challenges. The yearly incidence is estimated at about 4–10 per 100,000 patients worldwide; however, its real incidence is difficult to quantify.
1 – 3
The evolution of hip replacements has increased patients’ expectations in terms of function and longevity. The main goal of surgery is full restoration of the original biomechanical setting of the hip affected by osteoarthritis
The interest in treating hip pathologies, such as developmental dysplasia of the hip (DDH), femoroacetabular impingement (FAI) and labral tears in patients without radiographic signs of osteoarthritis (OA), has rapidly increased
Richard de SteigerAustralian Orthopaedic Association National Joint Replacement Registry (AOANJRR), Adelaide, Australia Department of Surgery, Epworth HealthCare, University of Melbourne, Melbourne, Australia
Martyn PorterThe National Joint Registry of England, Wales, Northern Ireland and Isle of Man Centre for Hip Surgery, Wrightington Hospital, Wrightington, Wigan and Leigh NHS Trust, Lancashire, United Kingdom
Søren OvergaardThe Danish Hip Arthroplasty Register Orthopaedic Research Unit, Department of Clinical Research, University of Southern Denmark, Odense, Denmark Department of Orthopaedic Surgery and Traumatology, Odense University Hospital, Odense, Denmark
The establishment of total hip arthroplasty (THA) registers started in the Scandinavian countries in 1979.
Later on, several countries outside Scandinavia followed with the establishment of nationwide or regional THA
Over the past two decades, substantial increase in the knowledge of pre-arthritic conditions of the hip joint including femoroacetabular impingement, development dysplasia of the hip, slipped capital femoral epiphysis, residual deformities after
Dislocation after total hip arthroplasty (THA) is a difficult problem for the patient, the treating surgeon, and is associated with a considerable extra cost for the health care system.
The true prevalence of post
further reduced infection. Despite the ongoing evolution and refinement of surgical practice, surgical site infection (SSI) remains a risk for every patient, including those undergoing primary total hip and knee arthroplasty procedures, and is associated
Developmental dysplasia of the hip (DDH) has a reported incidence of 3–4% in children under the age of 6 months. Actual dislocations are reported in 0.1–0.2% ( 1 ). If undiagnosed or untreated, consequences can be severe